• Contact
  • De
Vaccentis
  • Company
  • Products
  • Pipeline
  • Investor Relations
  • Blog
Select Page

vaccentis | Blog

Vaccentis appoints Martin Munte as CEO and strengthens Board

Vaccentis appoints Martin Munte as CEO and strengthens Board

by Philip | Jul 12, 2022 | Blog post, Newsletter

Martin Munte has extensive leadership experience at Amgen, AstraZeneca and Roche...
 
read more
Vaccentis AG reorganizes its Board of Directors

Vaccentis AG reorganizes its Board of Directors

by Philip | May 24, 2022 | Blog post, Newsletter

At its General Meeting on 19 May 2022, Vaccentis AG expanded its Board of Directors with...
 
read more
FBM-PHARMA: Preparations for autologous serum eye drops are on schedule

FBM-PHARMA: Preparations for autologous serum eye drops are on schedule

by Philip | Jan 20, 2019 | autologous serum eye drops, Blog post

Negotiations with collection centres in North Rhine-Westphalia and Saarland are well...
 
read more
Increased sales of AHIT® and urexent®

Increased sales of AHIT® and urexent®

by Philip | Jan 20, 2019 | Blog post

For AHIT® and urexent®, FBM-PHARMA has been able to increase its sales revenues in recent...
 
read more
FBM-PHARMA: Preparations for autologous serum eye drops are on schedule

Autologous serum eye drops – inclusion in the FBM-PHARMA product portfolio

by Philip | Aug 15, 2018 | autologous serum eye drops, Blog post

Patients suffering from “dry eye syndrome” diagnoses, such as...
 
read more

Vaccentis AG
Gerechtigkeitsgasse 25
CH – 8001 Zürich

info@vaccentis.ch

  • Company
  • Investors Relations
  • Products
  • ASAT
  • AHIT
  • Urexent
  • Pipeline
  • VCC-001
  • Blog
  • Subscribe Newsletter
  • Contact

© 2021 Vaccentis AG

  • Home
  • Contact
  • Imprint
  • Privacy Policy
Cookie-Zustimmung verwalten
Wir verwenden Cookies, um unsere Website und unseren Service zu optimieren.
Funktional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Vorlieben
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistiken
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
Vorlieben
{title} {title} {title}